In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.
about
Q feverFrom Q Fever to Coxiella burnetii Infection: a Paradigm Change.Acute Q fever with hemophagocytic syndrome: case report and literature review.Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.Newer macrolides as empiric treatment for acute Q fever infection.Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens.Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cellsSusceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells.Q fever in Quebec (1989-93): Report of 14 casesTreatment of Q feverIn vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycinAntimicrobial therapies for Q fever.Q fever in Plymouth, 1972-88. A review with particular reference to neurological manifestations.Coxiella burnetii blood cultures from acute and chronic Q-fever patients.Q fever endocarditis: a case report and review of the literatureIn vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin.Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis.Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.A plasmid-encoded surface protein found in chronic-disease isolates of Coxiella burnetti.Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.A review of the antimicrobial activity of the fluoroquinolones.Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes.Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.Q Fever endocarditis: does serology predict outcome?Two rare severe and fulminant presentations of Q fever in patients with minimal risk factors for this disease.Coxiella burnetii inhibits activation of host cell apoptosis through a mechanism that involves preventing cytochrome c release from mitochondria.Chronic Q fever: diagnosis and follow-up.Unexpected antibiotic susceptibility of a chronic isolate of Coxiella burnetii.Ciprofloxacin treatment of murine typhus.
P2860
Q24550722-224F590A-5CB5-4351-839A-6B4AB2DAB6A4Q30241105-4BB58159-7EFB-45E8-8666-DB99CC1572CFQ33373502-63544F86-97B7-4EE3-8AA0-3507FBE91679Q33619248-A0A9630A-FA2C-47A0-8B18-D73C26E6FB07Q33983769-214B3559-D58D-415E-B3B1-D8699DE02700Q34719806-5347788D-F887-499A-BE3F-9D87ED04D9FBQ34991405-CF371D77-063E-4166-983F-D522C17D6752Q35268754-D4568856-C7A1-411C-8322-76A4DDB84344Q35330868-683F9B95-DE46-428C-A863-665D9F086871Q35649923-859AB359-3EBF-40D4-83E8-046723F4D322Q35818504-B8428A2A-E587-4EFC-938D-8D3024652255Q35904249-9BA9887B-839E-4BFE-B88F-6A2A099AA79CQ36169968-902CA45C-0CBC-44A5-9E96-CBAF58805CEDQ36505212-9509C751-96AB-4555-B2A1-D46014D86FB8Q36526287-84AF9DEB-EFE4-421A-BFBF-F2221C1D2808Q36533905-234E9F7A-AD5D-4EE6-BDD6-A8D8863C0341Q36752586-079E32FB-91C5-4843-AF36-E19CA9F2E786Q36753137-8EACEDE0-D15B-4B30-8876-04B01846EE80Q36755802-DA130322-4C40-4A3C-A46A-71E66994C418Q36990892-516C6959-031F-4F1B-85B3-EC5E4573D2F2Q37204133-EFC469F9-FEA8-4BCE-B10C-7A407423A661Q37630321-36974A53-9D40-442E-84AE-015CB7EE3A41Q37834318-B12680F4-65E8-4E10-9A56-4475656EE4D6Q39476051-41D7B9E3-4565-483D-B46B-CFD198F6585FQ39479010-80BCD77A-C02A-468B-84F9-885AB05923ABQ39559260-0F4C1613-7BC3-4AC9-832E-F2CFCA5AB810Q39833040-22ADCFC4-8EDB-413B-9F82-B4D2068AF4C5Q40086579-A4778274-C7A6-4BAB-A1CD-CF10C3F7DCAAQ40284597-296F8289-03AF-4846-AD5A-D2A99F43762BQ40285408-EB002029-1310-42FE-AD8F-1B11D2C40510Q40437772-2CCC69C3-790C-4AAB-BF5A-FBC840B48E17Q40441498-9ADC8538-3F79-4D4A-B498-4EDDE2F8F9CFQ40766103-680C5636-F0DE-4A4A-B262-B243731BF06AQ40766145-7A329C6B-E390-48B6-AE8A-CDCCF11ABB7DQ40767135-AD936D81-EB78-4766-9370-9853796BADB7
P2860
In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
In vitro susceptibility of Cox ...... including several quinolones.
@en
In vitro susceptibility of Cox ...... including several quinolones.
@nl
type
label
In vitro susceptibility of Cox ...... including several quinolones.
@en
In vitro susceptibility of Cox ...... including several quinolones.
@nl
prefLabel
In vitro susceptibility of Cox ...... including several quinolones.
@en
In vitro susceptibility of Cox ...... including several quinolones.
@nl
P2093
P2860
P356
P1476
In vitro susceptibility of Cox ...... including several quinolones.
@en
P2093
P2860
P304
P356
10.1128/AAC.31.7.1079
P407
P577
1987-07-01T00:00:00Z